Matthew Harris
Fundador en CLARITY PHARMACEUTICALS LTD .
Fortuna: 34 M $ al 30/04/2024
Perfil
Matthew Harris is the founder and the Technology Director at Clarity Pharmaceuticals Ltd., a company founded in 2010.
He was previously the Chief Executive Officer at Gateway Capital Ltd.
and a Non-Executive Director at Genera Biosystems Ltd.
from 2007 to 2008.
Dr. Harris holds a doctorate degree from the Australian National University and an MBA from the Australian Graduate School of Management.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 08/04/2024 | 18 788 460 ( 6.93% ) | 34 M $ | 30/04/2024 |
Cargos activos de Matthew Harris
| Empresas | Cargo | Inicio |
|---|---|---|
| CLARITY PHARMACEUTICALS LTD | Fundador | 01/01/2010 |
Antiguos cargos conocidos de Matthew Harris.
| Empresas | Cargo | Fin |
|---|---|---|
| GENERA BIOSYSTEMS LIMITED | Director/Miembro de la Junta | 12/12/2008 |
Gateway Capital Ltd.
 Gateway Capital Ltd. Financial ConglomeratesFinance Gateway Capital Ltd. is an investment firm. | Presidente | - |
Formación de Matthew Harris.
| Australian Graduate School of Management | Masters Business Admin |
| Australian National University | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| CLARITY PHARMACEUTICALS LTD | Health Technology |
| Empresas privadas | 2 |
|---|---|
Gateway Capital Ltd.
Gateway Capital Ltd. Financial ConglomeratesFinance Gateway Capital Ltd. is an investment firm. | Finance |
Genera Biosystems Ltd.
 Genera Biosystems Ltd. Medical SpecialtiesHealth Technology Genera Biosystems Ltd. is a molecular diagnostics company, which engages in the development and commercialization of molecular diagnostic tests. Its products include PapType and RTIplex. The company was founded by Karl Poetter on November 6, 2001 and is headquartered in Scoresby, Australia. | Health Technology |
- Bolsa de valores
- Insiders
- Matthew Harris
